Neurofibromatosis type 1 molecular testing and clinical presentation of two cases

Neurofibromatosis type 1 is caused by mutations in the NF1 gene located on chromosome 17q. Case 1: A 1 year 7-month-old boy had progressive right ptosis which began when he was 19 months of age and numerous café-au-lait spots. Case 2: A 28 years old woman presents: café-au-lait spots, one subcutaneo...

Full description

Bibliographic Details
Main Authors: Crsitina Gug, Andrei Anghel, Liviu Tamas, Edward Seclman, Patrick Willems
Format: Article
Language:English
Published: "Alexandru Ioan Cuza" University of Iași 2010-06-01
Series:Analele Ştiinţifice Ale Universităţii Alexandru Ioan Cuza din Iași,Sectiunea II A : Genetica si Biologie Moleculara
Online Access:http://www.gbm.bio.uaic.ro/index.php/gbm/article/view/758
id doaj-8ee60881717f41758342c14fba7491ff
record_format Article
spelling doaj-8ee60881717f41758342c14fba7491ff2020-11-25T00:23:20Zeng"Alexandru Ioan Cuza" University of IașiAnalele Ştiinţifice Ale Universităţii Alexandru Ioan Cuza din Iași,Sectiunea II A : Genetica si Biologie Moleculara 1582-35712248-32762010-06-01112-3751Neurofibromatosis type 1 molecular testing and clinical presentation of two casesCrsitina GugAndrei AnghelLiviu TamasEdward SeclmanPatrick WillemsNeurofibromatosis type 1 is caused by mutations in the NF1 gene located on chromosome 17q. Case 1: A 1 year 7-month-old boy had progressive right ptosis which began when he was 19 months of age and numerous café-au-lait spots. Case 2: A 28 years old woman presents: café-au-lait spots, one subcutaneous tumor on the left leg, a first degree family member, who has NF1-malignant form. Molecular Genetic analysis consisted of: 1. Amplification of the entire coding region of the NF1 gene. 2. Screening for deletions and duplications in the NF1 gene by MLPA analysis. Results: Case 1: A heterozygous c.1719delT mutation was identified in exon 11 of the NF1 gene. Case 2: A heterozygous c.6709C>T mutation was identified in exon 45 of the NF1 gene. Conclusions: The mutations founded in both cases determined a truncated NF1 protein, which is disease-causing.http://www.gbm.bio.uaic.ro/index.php/gbm/article/view/758
collection DOAJ
language English
format Article
sources DOAJ
author Crsitina Gug
Andrei Anghel
Liviu Tamas
Edward Seclman
Patrick Willems
spellingShingle Crsitina Gug
Andrei Anghel
Liviu Tamas
Edward Seclman
Patrick Willems
Neurofibromatosis type 1 molecular testing and clinical presentation of two cases
Analele Ştiinţifice Ale Universităţii Alexandru Ioan Cuza din Iași,Sectiunea II A : Genetica si Biologie Moleculara
author_facet Crsitina Gug
Andrei Anghel
Liviu Tamas
Edward Seclman
Patrick Willems
author_sort Crsitina Gug
title Neurofibromatosis type 1 molecular testing and clinical presentation of two cases
title_short Neurofibromatosis type 1 molecular testing and clinical presentation of two cases
title_full Neurofibromatosis type 1 molecular testing and clinical presentation of two cases
title_fullStr Neurofibromatosis type 1 molecular testing and clinical presentation of two cases
title_full_unstemmed Neurofibromatosis type 1 molecular testing and clinical presentation of two cases
title_sort neurofibromatosis type 1 molecular testing and clinical presentation of two cases
publisher "Alexandru Ioan Cuza" University of Iași
series Analele Ştiinţifice Ale Universităţii Alexandru Ioan Cuza din Iași,Sectiunea II A : Genetica si Biologie Moleculara
issn 1582-3571
2248-3276
publishDate 2010-06-01
description Neurofibromatosis type 1 is caused by mutations in the NF1 gene located on chromosome 17q. Case 1: A 1 year 7-month-old boy had progressive right ptosis which began when he was 19 months of age and numerous café-au-lait spots. Case 2: A 28 years old woman presents: café-au-lait spots, one subcutaneous tumor on the left leg, a first degree family member, who has NF1-malignant form. Molecular Genetic analysis consisted of: 1. Amplification of the entire coding region of the NF1 gene. 2. Screening for deletions and duplications in the NF1 gene by MLPA analysis. Results: Case 1: A heterozygous c.1719delT mutation was identified in exon 11 of the NF1 gene. Case 2: A heterozygous c.6709C>T mutation was identified in exon 45 of the NF1 gene. Conclusions: The mutations founded in both cases determined a truncated NF1 protein, which is disease-causing.
url http://www.gbm.bio.uaic.ro/index.php/gbm/article/view/758
work_keys_str_mv AT crsitinagug neurofibromatosistype1moleculartestingandclinicalpresentationoftwocases
AT andreianghel neurofibromatosistype1moleculartestingandclinicalpresentationoftwocases
AT liviutamas neurofibromatosistype1moleculartestingandclinicalpresentationoftwocases
AT edwardseclman neurofibromatosistype1moleculartestingandclinicalpresentationoftwocases
AT patrickwillems neurofibromatosistype1moleculartestingandclinicalpresentationoftwocases
_version_ 1725357632231833600